Gene Editing In China: EdiGene Raises Fresh Funds, Aims For First IND
'Great Leap' From Gene-Edited Babies to One-Time Cures
With gene editing making the news again after the recent Nobel Prize for CRISPR, China’s EdiGene has been raising new funds to accelerate its pipeline to the clinic, led by a potential one-time cure for thalassemia and helped by recent regulatory changes.
